Ann: Positive BNC210 Phase 2 Anxiety Trial Results-BNO.AX, page-8

  1. 395 Posts.
    lightbulb Created with Sketch. 10
    As good as you could hope for from this size trial. With only 24 patients, they demonstrated both engagement of the drug at site of action and change in behaviour, allowing us to be fairly confident it was the drug causing those changes in behaviour. All very promising and bodes well for PIII. No report of safety in my fairly quick glance - therefore assume not an issue. I will be buying more.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.